CCM
Cinctive Capital Management Portfolio holdings
AUM
$1.79B
1-Year Return
33.04%
This Quarter Return
-1.24%
1 Year Return
+33.04%
3 Year Return
+118.69%
5 Year Return
+239.8%
10 Year Return
–
AUM
$1.26B
AUM Growth
-$601M
(-32%)
Cap. Flow
-$550M
Cap. Flow
% of AUM
-43.78%
Top 10 Holdings %
Top 10 Hldgs %
21.47%
Holding
473
New
141
Increased
53
Reduced
88
Closed
177
Top Buys
| 1 |
Kinder Morgan
KMI
|
$29.5M |
| 2 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$25.2M |
| 3 |
Allegro MicroSystems
ALGM
|
$23.7M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$19.6M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$18.5M |
Top Sells
| 1 |
Antero Midstream
AM
|
$37.6M |
| 2 |
Williams Companies
WMB
|
$36.8M |
| 3 |
DFS
Discover Financial Services
DFS
|
$36.1M |
| 4 |
Duke Energy
DUK
|
$34.4M |
| 5 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$29.3M |
Sector Composition
| 1 | Financials | 16.29% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 15.48% |
| 4 | Technology | 14.9% |
| 5 | Utilities | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
MoonLake Immunotherapeutics
MLTX
$3.77B
| – | – |
-10,576
| Closed | -$573K |
|
402
Monster Beverage
MNST
$61B
| – | – |
-27,833
| Closed | -$1.46M |
|
403
Morningstar
MORN
$10.8B
| – | – |
-4,313
| Closed | -$1.45M |
|
404
Moderna
MRNA
$9.78B
| – | – |
-15,842
| Closed | -$659K |
|
405
Marvell Technology
MRVL
$54.6B
| – | – |
-6,000
| Closed | -$663K |
|
406
Micron Technology
MU
$147B
| – | – |
-9,200
| Closed | -$774K |
|
407
NewAmsterdam Pharma
NAMS
$3.04B
| – | – |
-9,516
| Closed | -$245K |
|
|
PLYA
408
DELISTED
Playa Hotels & Resorts
PLYA
| – | – |
-257,369
| Closed | -$3.26M |
|
409
Insulet
PODD
$24.5B
| – | – |
-52,130
| Closed | -$13.6M |
|
410
Revvity
RVTY
$10.1B
| – | – |
-8,771
| Closed | -$979K |
|
411
Saia
SAIA
$8.34B
| – | – |
-7,850
| Closed | -$3.58M |
|
412
Saic
SAIC
$4.92B
| – | – |
0
| – | – |
|
413
Shake Shack
SHAK
$4.03B
| – | – |
-59,208
| Closed | -$7.69M |
|
414
J.M. Smucker
SJM
$12B
| – | – |
-19,262
| Closed | -$2.12M |
|
415
Skechers
SKX
$9.5B
| – | – |
-35,168
| Closed | -$2.36M |
|
416
Schlumberger
SLB
$53.4B
| – | – |
-26,449
| Closed | -$1.01M |
|
417
Soleno Therapeutics
SLNO
$3.71B
| – | – |
-13,223
| Closed | -$594K |
|
418
Summit Therapeutics
SMMT
$19.3B
| – | – |
-27,270
| Closed | -$487K |
|
419
Snap
SNAP
$12.4B
| – | – |
-347,182
| Closed | -$3.74M |
|
420
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
421
Stevanato
STVN
$6.59B
| – | – |
-83,156
| Closed | -$1.81M |
|
422
Spyre Therapeutics
SYRE
$1.03B
| – | – |
-19,567
| Closed | -$456K |
|
423
Molson Coors Class B
TAP
$9.96B
| – | – |
-11,854
| Closed | -$679K |
|
424
Teradyne
TER
$19.1B
| – | – |
-79,809
| Closed | -$10M |
|
425
Teva Pharmaceuticals
TEVA
$21.7B
| – | – |
-117,421
| Closed | -$2.59M |
|